SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is trending following reported 700% year-over-year revenue growth, fueled by recent expanded global approvals for its cancer therapies in the EU and Saudi Arabia. The community is buzzing with anticipation of a significant short squeeze and further label expansions, highlighting the immense potential of its diverse immunotherapy platform.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending after its CagriSema weight-loss drug trial achieved 23% weight loss but missed its primary endpoint of non-inferiority compared to Eli Lilly's tirzepatide, causing a significant stock drop. The community is debating whether this market reaction is an overblown response to a minor efficacy difference, creating a buying opportunity, or if it signals a tougher competitive landscape against its rival.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, NEREUS, Ponvory, and HETLIOZAccess. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Vanda Pharmaceuticals Inc

Vanda Pharmaceuticals is buzzing after securing FDA approval for BYSANTI, its new drug for bipolar I disorder and schizophrenia, a development the community sees as a significant re-rating catalyst due to its New Chemical Entity status and patent protection extending to 2044. This long-term exclusivity is fueling widespread speculation about potential buyout offers from major pharmaceutical companies and the stock's short squeeze potential, even as some investors eye commercial launch timelines and possible dilution.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors digest news of a significant stock sale filing from Trump's trust, fueling community discussions around potential dilution and the company's highly scrutinized financial viability. There is ongoing anticipation of upcoming reports and updates regarding a debated 'fusion deal' amidst concerns about its fundamental value.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera (ATOM) is trending as a recent direct stock offering at $5 sparks debate, with bulls viewing it as a strategic move to fund game-changing MST technology for AI and data centers, while bears voice skepticism over dilution given the company's pre-revenue status and historical performance.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is surging on overwhelmingly positive Phase 2 S-OLARIS trial results for sonelokimab in axSpA, which demonstrated exceptional efficacy and potential disease-modifying effects, further bolstered by a robust financial outlook. The community is actively discussing the drug's best-in-class potential, its significant market opportunity, and a major institutional buy-in, fueling expectations for a substantial re-evaluation and potential short squeeze ahead of its Investor Day.

Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Redwood City MD.

Arcellx Inc

Arcellx is trending as Gilead Sciences announced its acquisition for $7.8 billion, with the community focusing on the substantial premium and the strategic value of Arcellx's promising CAR T-cell therapy, anito-cel, which has shown strong clinical data for multiple myeloma.

Axsome Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which engages in the development of novel therapies for the management of central nervous system disorders. Its portfolio consists of Products Overview and Pipeline Overview. The Products Overview includes Auvelity and Sunosi. The Pipeline Overview refers to AXS-05, AXS-07, AXS-12, and AXS-14. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.

Axsome Therapeutics Inc

Axsome Therapeutics is trending due to the FDA granting Priority Review for AXS-05 in Alzheimer's disease agitation, setting an April PDUFA date, alongside robust Q4 earnings and strong commercial growth for its CNS therapies. The community is highly optimistic about AXS-05's market potential and the company's trajectory towards cash flow positivity, further supported by multiple analyst upgrades and pipeline advancements.

Domino's Pizza, Inc. engages in the management of a network of company-owned and franchise-owned pizza stores. It operates through the following segments: U.S. Stores, International Franchise, and Supply Chain. The U.S. Stores segment consists primarily of franchise operations. The International Franchise segment comprises a network of franchised stores. The Supply Chain segment manages regional dough manufacturing and food supply chain centers. The company was founded by James Monaghan and Thomas Stephen Monaghan in 1960 and is headquartered in Ann Arbor, MI.

Dominos Pizza Inc

Domino's is trending after reporting Q4 earnings with strong revenue and a dividend increase, though an EPS miss has fueled community debate over its "Hungry for MORE" strategy driving market share gains against competitive and macro pressures.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending as its mainnet launch and institutional validation, including its Coinbase 50 index inclusion, drive bullish conviction in its utility and long-term potential, yet the community remains sharply divided amid persistent price drops leading to strong skepticism about the project's viability.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Phoenix Motor Inc. (19% increase in followers)Anaheim, California-based Phoenix Motor makes electric buses and trucks for various service and government fleet markets.&nbsp;This year, the company drew considerable attention after reporting encouraging fiscal third-quarter results in February that showed revenue soaring by 1,557% to $4.77 million even as net losses widened.&nbsp;After posting these results, which were delayed earlier, it regained compliance with the Nasdaq listing.In February, the company established EdisonFuture International, a Hong Kong-based subsidiary focused on expanding its EV business globally, targeting markets in the Caribbean, South America, Europe, and Asia.&nbsp;For 2024, Phoenix Motor projects revenue of $30 million to $31 million, a tenfold increase from $3 million in 2023. It expects to turn profitable after reporting a net loss in the prior year,&nbsp;with revenue for fiscal year 2025 forecasted to be in the $40 million to $50 million range.Additionally, the company's board approved a $5 million share repurchase program last week.Phoenix Motor's stock has gained 9.5% this year.Chijet Motor Company Inc. (13% increase in followers)Chijet, a Chinese developer of next-generation electric vehicles, has not had any significant news catalysts this year.&nbsp;Last month, the company received a staff determination letter from Nasdaq, notifying Chijet of its impending delisting from the Nasdaq Global Market.&nbsp;The decision came after Chijet failed to regain compliance with the exchange's minimum market value requirements: $50 million for listed securities and $15 million for publicly held shares.During its listing on the Nasdaq in June 2023, Chijet said it has a pipeline of more than a dozen new vehicles and aims to launch its FB77, a pure electric sedan, and the R9 PHEV hybrid SUV in the coming years.The company had said that future models, including the FV20, FB21, and FB31, will span both commercial and passenger segments.Chijet's stock has lost over 20% this year.Zeekr Intelligent Technology Holding (10% increase in followers)Chinese electric vehicle maker Zeekr has been making headlines this year with strong monthly delivery numbers and reports of new premium launches.&nbsp;The Geely-owned automaker's own brand sales surged 86.9% year-over-year in February, and the recent Lynk &amp; Co acquisition boosted total deliveries.&nbsp;Zeekr is also set to unveil the ultra-luxury 9X Grand SUV this month in China, targeting high-end consumers and taking on brands like Mercedes-Benz and BMW.Zeekr stock has lost over 13% this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Visitors check ZEEKR 7X cars displayed at the 46th Bangkok International Motor Show 2025 in Nonthaburi province on the outskirts of Bangkok, Thailand, on March 28, 2025. (Photo by Anusak Laowilas/NurPhoto via Getty Images)

Phoenix Motor, Chijet, Zeekr: Retail Traders Flocked To These 3 Auto Stocks The Most In Q1

Although companies such as Tesla, Rivian and legacy automakers such as Ford and GM have dominated headlines this year, these lesser known brands captivated Stocktwits users more in Q1 2025. 

Equity

These five automobile-linked stocks notched the biggest jump in retail following on Stocktwits in the week ended Feb. 14, 2025:WeRide Inc. (+460% jump in following)Chinese self-driving startup WeRide surged to a record high after an SEC filing&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/wrd-stock-hits-record-high-on-nvidia-stake/ch5iISdRHD">revealed</a> that AI chip giant Nvidia had taken a stake, owning 1.7 million shares.&nbsp;According to The Fly, Morgan Stanley called the move a sign of growing investor enthusiasm for self-driving technology and the value of strategic alliances in the robotaxi space. The research firm has an 'Overweight' rating and a $23 price target on the stock, which is up 122% year-to-date (YTD).Phoenix Motor Inc. (+14% jump in following)Phoenix Motor regained Nasdaq compliance after resolving delays in its SEC filings, giving the stock a lift. Earlier in the week, the company posted fiscal third-quarter revenue of $4.8 million, up sharply from just $0.2 million a year earlier. It cited the successful integration of its transit segment and partnerships in AI and autonomous tech.&nbsp;Shares are up 25% YTD.Strattec Security Corporation (+8% jump in following)Auto security supplier Strattec continued its rally, likely fueled by strong earnings earlier in the month. Fiscal second-quarter net sales rose 9.6% to $129.9 million, beating estimates, driven by new program launches and rising volumes from key customers like GM and Ford. While sales to Stellantis lagged, demand was strong in North America, particularly from Hyundai.Shares are up nearly 19% YTD.Hesai Group (+5% jump in following)Lidar maker Hesai announced a deeper collaboration with Chinese EV giant BYD, providing lidar for more than 10 upcoming BYD models set for mass production in 2025. BYD, which sold over 4 million intelligent-driving-equipped vehicles last year, is integrating Hesai’s lidar into its next-gen “God’s Eye” ADAS system, expected to expand self-driving features across its lineup.&nbsp;Hesai’s stock is up over 29% YTD.Motorcar Parts of America (+2.5% jump in following)Motorcar Parts reported strong fiscal Q3 results as it swung to a profit, with revenue rising to $186.2 million from $171.9 million last year. CEO Selwyn Joffe highlighted the company’s leadership in the non-discretionary aftermarket parts sector and its focus on quality and customer service.&nbsp;Shares are up 24% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the WeRide, Inc. logo is displayed on a smartphone screen. (Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images)

Top 5 Auto Stocks That Had Retail Traders Revved Up Last Week

From AI giants taking a stake to earnings beats, these auto-linked stocks saw the biggest surge in new Stocktwits followers.

Phoenix Motor, Inc. designs, develops, manufactures, assembles, and integrates electric drive systems and light and medium duty electric vehicles, with an aim to reduce carbon intensity and greenhouse gas emissions. It operates under the brands Phoenix Motorcars, which is focused on commercial products including medium duty electric vehicles, chargers, and electric forklifts, and EdisonFuture, which intends to offer light-duty electric vehicles. The company was founded in 2003 and is headquartered in Anaheim, CA.

Current Price	$3.22
Prev Close	$3.74
Open	$3.18
Dividend Yield	0.00%
50-Day Moving Average	$4.35
Beta	1.93
Avg. Volume	980.93
PE Ratio	-0.19

52-Week High	$42.39
52-Week Low	$1.94
Market Capitalization	$4.31M
EPS (Annual)	$10.48
Price to Book	0.76
Revenue Per Employee	$195,937.11

PEV
Phoenix Motor Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest PEV News

PEV Phoenix Motor Inc